 |  | Bictegravir |  | Published
February 21, 2018; Updated
March 2018 | Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-07-04 |  | Selected Reference | 4. | Molina JM, Ward D, Brar I, et al. Switch to bictegravir/F/TAF from DTG and ABC/3TC. In: Program and abstracts of the 2018 Conference on Retroviruses and Opportunistic Infections; March 4-7, 2018; Boston. Abstract 22. |  |
|
|
|